Yokoyama Hiroyuki, Hirai Takashi, Nagata Tetsuya, Enomoto Mitsuhiro, Kaburagi Hidetoshi, Leiyo Li, Motoyoshi Takayuki, Yoshii Toshitaka, Okawa Atsushi, Yokota Takanori
Department of Orthopedic Surgery, Tokyo Medical and Dental University, Tokyo 113-8519, Japan.
Department of Neurology and Neurological Science, Tokyo Medical and Dental University, Tokyo 113-8519, Japan.
J Pain Res. 2020 Nov 20;13:3031-3043. doi: 10.2147/JPR.S272952. eCollection 2020.
Pathological stimuli or injury to the peripheral nervous system can trigger neuropathic pain with common clinical features such as allodynia and hypersensitivity. Although various studies have identified molecules or genes related to neuropathic pain, the essential components are still unclear. Therefore, in this study, we investigated the molecular and genetic factors related to neuropathic pain.
We extracted candidate genes in the dorsal root ganglion (DRG) from three nerve injury mouse models and a sham-operated model (sciatic nerve ligation and resection, sural nerve resection, spared nerve injury [SNI], and sham) using DNA microarray to elucidate the genes responsible for the neuropathic pain mechanism in the SNI model, which exhibits hypersensitivity in the hindpaw of the preserved sural nerve area. We eliminated as many biases as possible. We then focused on an upregulated endogenous vasopressin receptor and clarified whether it is closely associated with traumatic neuropathic pain using a knockout mouse and drug-mediated suppression of the gene.
Algorithm analysis of DNA microarray results identified 50 genes significantly upregulated in the DRG of the SNI model. Two independent genes-cyclin-dependent kinase-1 (CDK-1) and arginine vasopressin receptor 1A (V1a)-were subsequently identified as candidate SNI-specific genes in the DRG by quantitative PCR analysis. Administration of V1a agonist to wild-type SNI mice significantly alleviated neuropathic pain. However, V1a knockout mice did not exhibit higher hypersensitivity to mechanical stimulation than wild-type mice. In addition, V1a knockout mice showed similar pain behaviors after SNI to wild-type mice.
Through the DNA microarray analysis of several neuropathic models, we detected specific genes related to chronic pain. In particular, our results suggest that V1a in the DRG may partially contribute to the mechanism of neuropathic pain.
周围神经系统的病理刺激或损伤可引发神经性疼痛,其具有痛觉过敏和超敏反应等常见临床特征。尽管多项研究已鉴定出与神经性疼痛相关的分子或基因,但其关键成分仍不明确。因此,在本研究中,我们调查了与神经性疼痛相关的分子和遗传因素。
我们使用DNA微阵列从三种神经损伤小鼠模型和一个假手术模型(坐骨神经结扎和切除、腓肠神经切除、保留神经损伤[SNI]以及假手术)的背根神经节(DRG)中提取候选基因,以阐明在保留的腓肠神经区域后爪表现出超敏反应的SNI模型中负责神经性疼痛机制的基因。我们尽可能消除了诸多偏差。然后,我们聚焦于一种上调的内源性血管加压素受体,并使用基因敲除小鼠和药物介导的基因抑制来阐明它是否与创伤性神经性疼痛密切相关。
DNA微阵列结果的算法分析确定了在SNI模型的DRG中显著上调的50个基因。随后通过定量PCR分析在DRG中鉴定出两个独立基因——细胞周期蛋白依赖性激酶-1(CDK-1)和精氨酸血管加压素受体1A(V1a)作为候选的SNI特异性基因。向野生型SNI小鼠施用V1a激动剂可显著减轻神经性疼痛。然而,V1a基因敲除小鼠对机械刺激的超敏反应并不高于野生型小鼠。此外,V1a基因敲除小鼠在SNI后的疼痛行为与野生型小鼠相似。
通过对几种神经性模型的DNA微阵列分析,我们检测到了与慢性疼痛相关的特定基因。特别是,我们的结果表明DRG中的V1a可能部分促成神经性疼痛的机制。